eISSN: 2449-9315
ISSN: 1234-8279
Pharmacotherapy in Psychiatry and Neurology/Farmakoterapia w Psychiatrii i Neurologii
Current issue Archive Manuscripts accepted About the journal Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
 
1/2022
vol. 38
 
Share:
Share:
more
 
 
Original article

Relationships between the pharmacological treatment method and negative symptoms, depression, social functioning and quality of life in schizophrenia patients during 11–15 years after a first psychiatric hospitalisation

Krystyna Jaracz
1
,
Krystyna Górna
2
,
Justyna Kiejda
2
,
Katarzyna Gołębiewska
2
,
Jan Jaracz
3

1.
Department of Neurological Nursing, Poznan University of Medical Sciences, Poznan, Poland;
Zakład Pielęgniarstwa Neurologicznego, Uniwersytet Medyczny w Poznaniu, Polska
2.
Department of Psychiatric Nursing, Poznan University of Medical Sciences, Poznan, Poland;
Zakład Pielęgniarstwa Psychiatrycznego, Uniwersytet Medyczny w Poznaniu
3.
Department of Adult Psychiatry, Poznan University of Medical Sciences, Poznan, Poland;
Klinika Psychiatrii Dorosłych, Uniwersytet Medyczny w Poznaniu, Polska
Farmakoterapia w Psychiatrii i Neurologii 2022, 38 (1), 23–33
Online publish date: 2022/08/02
Article file
Get citation
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
PlumX metrics:
 
1. Addington D, Addington J, Maticka-Tyndale E. Assessing depression in schizophrenia: the Calgary Depression Scale. Br J Psychiatry. Suppl. 1993; 22: 39-44.
2. Birchwood M, Smith J, Cochrane R, Wetton S, Copestake S. The Social Functioning Scale. The development and validation of a new scale of social adjustment for use in family intervention programmes with schizophrenic patients. Br J Psychiatry 1990;157: 853-859.
3. Bobes J, Arango C, Garcia-Garcia M, Rejas J. CLAMORS Study Collaborative Group. Prevalence of negative symptoms in outpatients with schizophrenia spectrum disorders treated with antipsychotics in routine clinical practice: findings from the CLAMORS study. J Clin Psychiatry 2010; 71(3): 280-286.
4. Bucci P, Mucci A, van Rossum IW, Aiello C, Arango C, Baandrup L i wsp. Persistent negative symptoms in recent-onset psychosis: Relationship to treatment response and psychosocial functioning. Eur Neuropsychopharmacol 2020; 34: 76-86.
5. Cerveri G, Gesi C, Mencacci C. Pharmacological treatment of negative symptoms in schizophrenia: update and proposal of a clinical algorithm. Neuropsychiatr Dis Treat 2019; 15: 1525-1535.
6. Correll CU, Schooler NR. Negative symptoms in schizophrenia: A review and clinical guide for recognition, assessment, and treatment. Neuropsychiatr Dis Treat 2020; 16: 519-534.
7. Galderisi S, Kaiser S, Bitter I, Nordentoft M, Mucci A, Sabé M i wsp. EPA guidance on treatment of negative symptoms in schizophrenia. Eur Psychiatry 2021; 64(1): e21. (a)
8. Galderisi S, Mucci A, Dollfus S, Nordentoft M, Falkai P, Kaiser S i wsp. EPA guidance on assessment of negative symptoms in schizophrenia. Eur Psychiatry 2021; 1864(1): e23. (b)
9. García-Fernández L, Romero-Ferreiro V, Sánchez-Pastor L, Dompablo M, Martínez-Gras I, Espejo-Saavedra JM i wsp. Impact of negative symptoms on functioning and quality of life in first psychotic episodes of schizophrenia. J Clin Med 2022; 11(4): 983.
10. Górna K, Jaracz K, Jaracz J, Kiejda J, Grabowska-Fudala B, Rybakowski J. Funkcjonowanie społeczne i jakość życia u chorych na schizofrenię – zależność z remisją objawową i czasem trwania choroby. Psychiatr Pol. 2014; 48(2): 277-88.
11. Górna K, Jaracz K, Rybakowski F, Rybakowski J. Determinants of objective and subjective quality of life in first-time-admission schizophrenic patients in Poland: a longitudinal study. Qual Life Res. 2008; 17(2): 237-247.
12. an der Heiden W, Leber A, Häfner H. Negative symptoms and their association with depressive symptoms in the long-term course of schizophrenia. Eur Arch Psychiatry Clin Neurosci 2016; 266(5): 387-396.
13. Jaracz J, Tetera-Rudnicka E, Kujath D, Raczyńska A, Stoszek S, Czernaś W i wsp. The prevalence of antipsychotic polypharmacy in schizophrenic patients discharged from psychiatric units in Poland. Pharmacol Rep 2014; 66(4): 613-617.
14. Jaracz K, Górna K, Kiejda J, Grabowska-Fudala B, Jaracz J, Suwalska A, Rybakowski JK. Psychosocial functioning in relation to symptomatic remission: A longitudinal study of first episode schizophrenia. Eur Psychiatry 2015; 30(8): 907-913.
Quick links
© 2023 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.